RGBP Company Profile and Key Details

Q: Who are the executives of RGBP?

Dr. David Raymond Koos DBA, Ph.D.Chairman, Chief Executive Officer, Pres, Sec. & TreasurerDr. David Raymond KoosChairman, Chief Executive Officer, Pres, Sec. & Treasurer

PNK : RGBP

Regen BioPharma

$1.10

-0.08-6.78%

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Regen BioPharma, Inc. (RGBP) stock surged +100.00%, trading at $0.00 on OTC, up from the previous close of $0.00. The stock opened at $0.00, fluctuating between $0.00 and $0.00 in the recent session.

Stock Snapshot

0.0001

Prev. Close

6.31K

Market Cap

0.000099999997

Day Low

-0.01

P/E Ratio

-0.01984

EPS (TTM)

-0.08

Cash Flow per Share

Open

31.55M

Number of Shares

0.0002

Day High

88.8%

Free Float in %

-1.31

Book Value

1.31M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 11, 2026	0.00	0.00	0.00	0.00	2.07M
Sep 10, 2026	0.00	0.00	0.00	0.00	7.06M
Sep 09, 2026	0.00	0.00	0.00	0.00	403.42K
Sep 08, 2026	0.00	0.00	0.00	0.00	10.16M
Sep 04, 2026	0.00	0.00	0.00	0.00	9.83M
Sep 03, 2026	0.00	0.00	0.00	0.00	0
Sep 02, 2026	0.00	0.00	0.00	0.00	2.5M
Sep 01, 2026	0.00	0.00	0.00	0.00	13.65M
Aug 31, 2026	0.00	0.00	0.00	0.00	37.28M
Aug 28, 2026	0.00	0.00	0.00	0.00	71.77M
Aug 27, 2026	0.00	0.00	0.00	0.00	19.32M
Aug 26, 2026	0.00	0.00	0.00	0.00	64.7M
Aug 25, 2026	0.00	0.00	0.00	0.00	9.75M
Aug 24, 2026	0.00	0.00	0.00	0.00	1.13M
Aug 21, 2026	0.00	0.00	0.00	0.00	15.04M
Aug 20, 2026	0.00	0.00	0.00	0.00	4.77M
Aug 19, 2026	0.00	0.00	0.00	0.00	14.8M
Aug 18, 2026	0.00	0.00	0.00	0.00	172.29K
Aug 17, 2026	0.00	0.00	0.00	0.00	2.37M
Aug 14, 2026	0.00	0.00	0.00	0.00	1.44M

Contact Details

La Mesa, CA 91942

United States

https://www.regenbiopharmainc.com 619 722 5505

About Company

Regen BioPharma, Inc. is a company dedicated to advancing regenerative medicine within the United States. It actively researches and identifies small molecule compounds designed to modulate the NR2F6 gene. This modulation is strategically aimed at activating immune cells for oncology treatments and suppressing them for autoimmune conditions. Its therapeutic pipeline and product development are currently in their initial phases. Established in 2012, the firm operates from its headquarters in La Mesa, California.

Stock Peers

LZAGF

-5-0.92%

Lonza Group AG$541.00 GNMSF

Genmab A/S$268.61 CMXHF

CSL Limited$192.00 CSLLY

0.75+0.79%

CSL Limited$95.35 UCBJY

-0.06-0.08%

UCB SA$73.15 LZAGY

-0.33-0.61%

Lonza Group AG$53.87 PHMMF

4.3+16.01%

Pharma Mar, S.A.$31.15 BVNKF

Bavarian Nordic A/S$21.20 GRTX

1.53+9.80%

Galera Therapeutics, Inc.$17.15 NURPF

Neuren Pharmaceuticals Limited$14.00

Company Overview

The stock is currently mid-range between its 52-week high and low $0.00 and $0.04. With a market capitalization of about $6.31 thousand, Regen BioPharma, Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~0.23). Key stats such as the average daily volume over the past year has been around 25.19 million shares, volume is running light vs its 52-week average. Headquartered in La Mesa, CA, Regen BioPharma, Inc. operates in the Healthcare sector and the Biotechnology industry. Led by CEO David Raymond Koos, the company employs approximately 1 people and listed since October 06, 2014. Regen BioPharma, Inc. is a company dedicated to advancing regenerative medicine within the United States.

Technical Performance

Average 10-day trading volume of 4.57 million shares is below the 3-month average of 26.36 million, indicating normal recent market interest.

Valuation Metrics

Regen BioPharma, Inc. trades at a P/E ratio of -0.01, slightly below the S&P 500 average, with a price-to-sales ratio of 0.03 and a price-to-book ratio of -0.02 indicating negative book value, which may reflect financial stress. The P/FCF stands at -0.01, also above market averages.

Dividend & Fair Value

Regen BioPharma, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.95. This means the shares are trading below this model’s fair value.

Financial & Profitability Overview

Over the trailing twelve months, Regen BioPharma generated $126.56K in revenue, or $0.01 per share. Gross margin was 28.89%, operating margin -267.49%, and net profit margin -1007.03%. Returns are negative, with ROA at -360.42% and ROE at 24.97%.
On valuation metrics, Regen BioPharma trades at a P/E of -0.01, P/S of 0.03 and P/B of -0.02. Liquidity is tight, with a current ratio of 0.05 and quick ratio of 0.05. Operationally, the company’s inventory turnover is 0.00 and cash conversion cycle is 443.05 days. Debt-to-equity is -0.16, supported by a cash flow-to-debt ratio of -0.48.

Quarterly Financial Highlights

For the quarter ended Sep 30, 2025, Regen BioPharma posted revenue of $126.56K, down slightly from $236.56K in the prior quarter. Gross profit was $36.56K (margin 28.89%). Operating income was - $338.54K (margin -267.5%). Net income was- $1.27M (EPS - $0.05).
The company ended the quarter with $121.04K in cash and short-term investments, a total debt of $756.20K, and net debt of $635.17K. Total assets were $353.62K, with equity of - $5.10M. Financials further reflected weakness, with operating cash flow of - $173.92K, free cash flow of - $173.92K, and capital expenditures of $0.00.

Price Forecast & Outlook

Our AI price prediction model suggests that Regen BioPharma, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

Key Takeaways

Valuation shows Regen BioPharma, Inc. trading at a premium to the broader market with a P/E of -0.01.

Frequently Asked Questions

What is the current Regen BioPharma, Inc. (RGBP) stock price?

Regen BioPharma, Inc. (OTC: RGBP) stock price is $0.00 in the last trading session. During the trading session, RGBP stock reached the peak price of $0.00 while $0.00 was the lowest point it dropped to. The percentage change in RGBP stock occurred in the recent session was 100% while the dollar amount for the price change in RGBP stock was $0.00.

RGBP's industry and sector of operation?

The OTC listed RGBP is part of Biotechnology industry that operates in the broader Healthcare sector. Regen BioPharma, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of RGBP?

Dr. David Raymond Koos DBA, Ph.D.
Chairman, Chief Executive Officer, Pres, Sec. & Treasurer
Dr. David Raymond Koos
Chairman, Chief Executive Officer, Pres, Sec. & Treasurer

How RGBP did perform over past 52-week?

RGBP's closing price is 174.31% higher than its 52-week low of $0.00 where as its distance from 52-week high of $0.04 is -46.34%.

How many employees does RGBP have?

Number of RGBP employees currently stands at 1.

Link for RGBP official website?

Official Website of RGBP is: https://www.regenbiopharmainc.com

How do I contact RGBP?

RGBP could be contacted at phone 619 722 5505 and can also be accessed through its website. RGBP operates from 8697 La Mesa Boulevard, La Mesa, CA 91942, United States.

How many shares of RGBP are traded daily?

RGBP stock volume for the day was 1.31M shares. The average number of RGBP shares traded daily for last 3 months was 25.19M.

What is the market cap of RGBP currently?

The market value of RGBP currently stands at $6.31K with its latest stock price at $0.00 and 31.55M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	1
Beta	0.23
Sales or Revenue	$126.56K
5Y Sales Change%	-0.932%
Fiscal Year Ends	September
Sector	Healthcare
Industry	Biotechnology

RGBP Company Profile and Key Details

Regen BioPharma

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Dividend & Fair Value

Company Overview

Technical Performance

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Valuation Metrics